Kopran has informed that it has enclosed certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 for the half year ended 31st March, 2020, dated 20th April, 2020 issued by Nirali Mehta, Practicing Company Secretary (Membership No. A37734, COP No. 20754). As per the relaxation, with reference to the email received from the stock exchanges regarding Guidelines for submission in the wake of CoVID19 virus dated 24th March, 2020 and 25th March, 2020, the company requested the Exchange to take this unsigned letter on record as duly signed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: